top of page
Search


Recce Pharmaceuticals – working on the global health challenge of sepsis and superbugs
In 2020 The World Health Organization (WHO) released its first report on the global epidemiology and burden of sepsis. The report...
Jun 14, 20234 min read
331 views
0 comments


Antisense Therapeutics Shares up 40% in a month. Strong Volume in Europe.
European investors have shown strong interest in Antisense Therapeutics Limited (ASX: ANP: FWB: AWY) since the company was dual listed in...
Apr 15, 20214 min read
527 views
0 comments


Major global trends driving biotech investment in 2021
Platform technology Using mRNA as a medicine is a radically different approach than treating disease with other drug classes. mRNA is the...
Mar 10, 20217 min read
2,326 views
0 comments


A global biotech leader in synthetic anti-infectives dual lists in Germany
Recce Pharmaceuticals Ltd (ASX: RCE) and (FSE: R9Q) is pioneering a new class of synthetic anti-infectives to address the urgent global...
Mar 8, 20213 min read
425 views
0 comments


Antisense shares have increased by 60% after Sarepta results
Antisense Therapeutics (ASX: ANP) and (FRA: AWY) are up over 60% in 2 months. 2 major reasons for this: Sarpeta Therapeutics announced...
Jan 8, 20212 min read
1,000 views
0 comments


Immutep Limited - a global leader in development of immunotherapy for cancer & autoimmune diseases
Immutep (ASX: IMM) and (FRA: YP1B) are the global leaders in understanding and development of therapeutics that modulate Lymphocyte...
Dec 16, 20204 min read
85 views
0 comments


Australian biotech companies becoming global players
Australia has ranked in the top five globally for biotechnology three years running, outperforming nations such as the United Kingdom and...
Nov 27, 20203 min read
93 views
0 comments
bottom of page